RebrAIn’s news

ActuIA Features RebrAIn’s Innovations in Supervised AI-Driven Deep Brain Stimulation

RebrAIn Featured by ActuIA for Pioneering Supervised AI-Driven Deep Brain Stimulation Targeting

We are excited to share that RebrAIn has been featured by ActuIA for our innovative work in neurosurgical targeting for Deep Brain Stimulation (DBS).

The article highlights our supervised AI-driven solutions that significantly improve patient outcomes for those with Parkinson’s Disease and Essential Tremor. Founded by Professor Emmanuel Cuny and Dr. Nejib Zemzemi, RebrAIn is transforming the landscape of neurosurgery with our precise and effective treatments.

Read the full article, “Focus on RebrAIn, the start-up that aims to revolutionize the surgical targeting of Deep Brain Stimulation”, in French on actuia.com here.

An English translation by Google is available here.

Back to Resources

Our latest public updates

Challenges showcases RebrAIn’s AI-powered innovation in Parkinson’s surgery

Mar 27, 2025

Challenges underscores the significance of RebrAIn's technology in enhancing the precision and efficiency of deep brain stimulation (DBS) surgeries. By leveraging machine learning algorithms trained on extensive clinical data, RebrAIn's software assists neurosurgeons...

From Patient to Practice: RebrAIn Wins the Resah Tender

Mar 19, 2025

The Strategic Importance of This Tender This success marks a major strategic turning point for RebrAIn, as the Resah procurement center plays a key role in the public healthcare sector in France. By enabling the member hospitals to choose the most effective...

The FUS Foundation highlights RebrAIn’s advances and validates its Board

Oct 12, 2024

Recently, the Focused Ultrasound Foundation highlighted RebrAIn's success in obtaining its second FDA 510(k) approval - which extends the capabilities of its OptimMRI software to include new machine learning models for lesioning treatment of Essential Tremor, thereby...

« Older Entries